Search
Now showing items 1-9 of 9
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling
(Research Policy, 2020-09-12)
We provide causal evidence that regulation induced product shocks significantly impact aggregate demand and firm performance in pharmaceutical markets. Event study results suggest an average loss between $569 million and ...
Intellectual property regimes and wage inequality
(Elsevier, 2021-07-19)
We use The Patents (Amendment) Act, 2002 in India as a quasi-natural experiment to identify the causal effect of higher incentives for innovation on a firm’s compensation structure. We find that stronger intellectual ...
How does regulation impact strategic repositioning by firms across submarkets? evidence from the Indian pharmaceutical industry
(INFORMS: Institute for Operations Research and the Management Sciences, 2021-02-09)
We study coercive institutional pressures as an impetus for firms to reposition across intraindustry boundaries. Integrating the literatures on strategic repositioning and submarkets, we predict that firms respond to ...
Women’s disempowerment and preferences for skin lightening products that reinforce Colorism: experimental evidence from India
(SAGE Publications, 2021-02-25)
Global racism and colorism, the preference for fairer skin even within ethnic and racial groups, leads millions of women of African, Asian, and Latin descent to use products with chemical ingredients intended to lighten ...
Generic competition and the incentives for early-stage pharmaceutical innovation
(Elsevier, 2022-12-01)
What impact has rising generic competition had on the nature and direction of pharmaceutical innovation? We find broad-based, strong evidence that pharmaceutical companies have diverted their new drug development efforts ...
Movies, stigma and choice: evidence from the pharmaceutical industry
(Wiley, 2023-02-02)
Do movies reduce stigma, increasing healthcare product choices offered by firms? We provide causal evidence on this question in the context of Indian pharmaceutical markets. For unpacking these effects, we use an exogenous ...
Cross-border environmental regulation and firm labor demand
(Elsevier, 2022-11-07)
In 1994, due to environmental concerns, Germany banned a chemical called ‘Azo-dyes’, a primary input for the leather and textiles firms in India (a key exporter). Exploiting this as a quasi-natural experiment, we examine ...
How do MNEs and domestic firms respond locally to a global demand shock? evidence from a pandemic
(PubsOnLine, 2022-03-23)
Global shocks bring unanticipated changes in the business environment of foreign multinational enterprises (MNEs) and rival domestic firms. We examine whether there is a difference between how MNEs and domestic firms react ...
Research and market structure: evidence from an antibiotic-resistant pathogenic outbreak
(Elsevier, 2023-01)
We provide causal evidence that upstream research shocks impact unconnected downstream product markets. Focusing on the Indian pharmaceutical market, we use a natural experiment involving a publication that identified a ...